Sulforaphane, but not GRA, caused G 2 /M-phase arrest (P ϭ 0.028) and increase of apoptotic cell fraction (P Ͻ 0.0001) in a time-and dose-dependent manner. Necrosis was observed after prolonged exposure to elevated sulforaphane doses. Moreover, it markedly increased p53 and bax protein expression, and slightly affected bcl-2 expression. These findings indicate that sulforaphane but not the native GL GRA can exert both protective and toxic effects inhibiting leukemic cell growth. Sulforaphane therefore deserves study as a potential chemopreventive/ chemotherapeutic antileukemic agent.
Introduction
Cancer chemoprevention involves preventing, delaying or reversing carcinogenesis by administering non-toxic synthetic chemicals or chemicals from natural substances before malignancy (1) . A number of agents have been reported to be effective against chemical carcinogenesis in several organs, and some are candidates for the inhibition of human cancer development (2) (3) (4) . The multifactorial nature of the carcinoAbbreviations: EB, ethidium bromide; FITC, fluorescein isothiocyanate; FSC, forward scatter; GL, glucosinolate; GRA, glucoraphanin; GSH, Glutathione; ITC, isothiocyanate; Myr, myrosinase; PI, propidium iodide; SSC, side scatter.
genic process provides numerous pathways that could be manipulated by these agents in order to inhibit or delay tumor development (5) . As a result of the wide variety of possible chemopreventive agents, short-term screening assays are being developed to help identify potentially effective compounds (6) .
Edible brassicas (e.g. broccoli and cauliflower) contain substantial quantities of biosynthesized secondary metabolites known as glucosinolates (GLs), as well as myrosinase (Myr) (thioglucoside glucohydrolase; EC 3.2.3.1). When the vegetables are crushed by chopping or chewing, Myr catalyzes a rapid hydrolytic reaction in which the GLs are then converted into isothiocyanates (ITCs) and other products, depending on the chemical structure of GL side chains (7) . Many synthetic ITCs exert versatile chemopreventive effects against tumors induced by chemical carcinogens in various animal organs, suggesting that common mechanisms underlie their chemopreventive properties (8, 9) . Two sets of putative mechanisms have been identified that help to explain the effects of ITCs. The first involves modulation of enzymes that are required for the activation or detoxification of many carcinogens (10, 11) . In particular, ITCs have been shown to induce the activity of phase II enzymes (e.g. glutathione S-transferase, quinone reductase and glucuronosyltransferases) and/or inhibit phase I enzymes (12) (13) (14) . Recent studies in humans also revealed that a high consumption of brassicas led to an increase in glutathione S-transferase activity, supporting the potential role of ITCs in the prevention of human cancer (15) . The second set of putative mechanisms involves suppression of tumor development following the initiation of pre-cancerous cells (16) . Possible mechanisms of suppression include the deletion of initiated cells from genetically damaged tissue by apoptosis, so that clonal expansion of the lesion is aborted (17) . Some constituents of brassicas have already been shown to induce apoptosis or block proliferation in cancer cells in vitro. In particular, Huang et al. (18) showed that phenylethyl ITC induces p53 transactivation in mouse epidermal cells in a dose-and timedependent fashion, while Gamet-Payrastre et al. demonstrated that sulforaphane induces cell-cycle arrest and apoptosis in HT29 human colon cancer cells (19) .
Most of these studies were performed using synthetic ITCs, which are commonly assumed to correspond to major natural constituents of cruciferous vegetables. However, this is not literally so, as sulforaphane only appears as the product of enzymatic degradation of its naturally occurring parent GL, namely glucoraphanin (GRA). Therefore, dietary exposure to sulforaphane, and indeed other ITCs, actually occurs as a result of the hydrolytic breakdown of precursor GLs on ingestion (e.g. by chewing raw vegetables in salads). Although cooking degrades the Myr present in broccoli, sulforaphane may also be produced in the human intestine, where microflora seem to promote the hydrolysis of GLs into ITCs (20) .
In order to mimic more closely the circumstances of dietary contact with sulforaphane following consumption of brassicas and to expand our knowledge on the chemopreventive potential of ITCs, we decided to study the effects of the mixture of GRA and Myr to produce sulforaphane on cell growth, cellcycle progression and apoptosis induction in Jurkat cells (i.e. human T-cell leukemia). We also assessed the apoptotic response of Jurkat cells in terms of p53, bcl-2 and bax expression.
We demonstrate for the first time that the ITC sulforaphane generated in situ by Myr but not the native precursor GRA induces apoptosis and perturbs cell-cycle progression in Jurkat cells. In this way, it was possible to compare the effect of the native GL GRA and of the ITC sulforaphane. We also found that sulforaphane increases p53 and bax protein level, but does not influence bcl-2.
Materials and methods
Production of GRA, Myr and sulforaphane GRA was obtained by a recently developed procedure (21) whereby a quantitative yield is produced starting from glucoerucin. Glucoerucin was isolated with a high purity grade from the ripe seeds of rocket (Eruca sativa Miller), according to a well-defined protocol (22) . The transformation of glucoerucin into GRA is based on the oxidation reaction of sulfides into their corresponding sulfoxides. The semi-synthetic GRA produced was purified according to the method reported by Visentin et al. (22) . Purity was assessed by HPLC analysis of the desulfo-derivative according to the ISO 9167-1 method (23) . The Myr used in the present study was isolated from ripe seeds of white mustards (Sinapis alba L.), as reported by Pessina et al. (24) . The Myr stock solution had a specific activity of~60 U/mg of soluble protein.
One Myr unit was defined as the amount of enzyme able to hydrolyze 1 µmol of sinigrin/min at pH 6.5 and 37°C. Myr solution was stored at 4°C in sterile distilled water until use.
Sulforaphane was generated in situ by Myr-catalyzed hydrolysis of GRA ( Figure 1 ). In our experimental conditions of cell culturing (pH 7.4, 37°C), sulforaphane is the only enzymatic breakdown product. The formation of sulforaphane was quantitative, as confirmed by GC-MS techniques (25) .
Cell culture
Jurkat T-leukemia cells were grown in suspension and propagated in RPMI 1640 supplemented with 10% heat-inactivated bovine serum, 1% antibiotics (all obtained from Sigma, St Louis, MO). To maintain exponential growth, the cultures were divided every third day by dilution to a concentration of 1ϫ10 5 cells/ml.
Cell treatment
A 4 mM stock solution of GRA was prepared in 0.9% NaCl and stored at 4°C. Samples (0.23 U) of Myr were directly added to 5 ml of the complete cell-culture medium containing increasing concentrations of GRA (3, 10 and 30 µM), prepared by diluting the stock solution with 0.9% NaCl. Exponentially growing Jurkat cells at a concentration of 400 000 cells/ml were subsequently added. The activity of native GRA or Myr was tested by treating the cell cultures with 30 µM GRA in absence of the enzyme or with Myr in absence of GRA, respectively. NaCl (0.9%) was used as control. For each experiment, treatments were done in duplicate and separate cultures were set up for each treatment.
Cytotoxicity test
In separate experiments, the GRA-Myr mixture was added at various concentrations to exponentially growing cells. Cell concentrations were measured as a function of time by counting trypan blue-excluding cells on cell aliquots removed from culture at the designated times (2, 4, 8, 12, 24 and 48 h). Results were calculated as viable cells in GRA-Myr mixture-treated cultures relative to control. ID 50 , the drug concentration causing cell toxicity by 50% 582 following a 24 h exposure, was calculated by interpolation from dose-response curves (26) .
Flow cytometry
Flow cytometry was performed using a FACStar ϩ flow cytometer (Becton Dickinson, Sunnyvale, CA) equipped with an argon laser (Innova 90; Coherent Radiation, Palo Alto, CA) operating at 488 nm (500 mW) for excitation of the ethidium bromide (EB).
Flow cytometric measurement of cell proliferation
The preparation of samples for measurements of the cell-cycle distribution of nuclei by DNA content was performed according to a two-step method reported elsewhere (27, 28) . Briefly, cultures were centrifuged for 5 min at 800 g and treated with 1 ml of solution I (584 mg/l NaCl, 1000 mg/l Nacitrate, 25 mg/l EB, 10 mg/l RNase and 0.3 ml/l Nonidet P-40). Then, after 1 h, 1 ml of solution II (15 g/l citric acid, 0.25 M sucrose and 40 mg/l EB) was added and the samples were briefly vortexed. EB fluorescence, forward scatter (FSC) and side scatter (SSC) of nuclei in suspension, measured using a combination of KV550 and OG590 longpass filters (Schott, Mainz, Germany), were recorded for cell nuclei in list mode. For each sample, 10 000 events were registered. The fraction of cells in the different compartments of cell cycle was calculated as described by Schreiber et al. (29) .
Measurement of annexin V binding by flow cytometry
It has been shown that loss of phospholipid asymmetry of the plasma membrane is an early event of apoptosis (30, 31) . The annexin V binds to negatively charged phospholipids, like phosphatidylserine. During apoptosis, the cells react to annexin V once chromatin condenses but before the plasma membrane loses its ability to exclude propidium iodide (PI). Hence, by staining cells with a combination of fluorescein isothiocyanate (FITC) annexin V and PI it is possible to detect non-apoptotic live cells, early apoptotic cells and late apoptotic or necrotic cells (32, 33) .
Cells from exponentially growing cultures were collected at different times. Aliquots of 0.5ϫ10 6 cells were centrifuged (100 g) for 5 min and washed with phosphate-buffered saline (PBS: NaCl 145 mM in phosphate buffer 150 mM). The cell pellet was resuspended in 100 µl of labeling solution (ANNEXIN-V-FLUOS, Boehringer Mannheim, Mannheim, Germany) containing 2 ml annexin V labeling reagent and 0.1 µg PI (Sigma) and incubated for 10-15 min, as per manufacturer's instructions. Immediately after adding 0.1 ml of incubation buffer (10 mM HEPES/NaOH, 140 mM NaCl, 5 mM CaCl 2 ), green (FITC) and red (PI uptake) fluorescence of individual cells was measured with a FACStar ϩ flow cytometer (Becton Dickinson), using 488 nm excitation and a 530 nm bandpass filter for FITC detection and a filter Ͼ590 nm for PI detection. For each sample, 10 000 events were registered. Electronic compensation was required to exclude overlapping of the two emission spectra.
Flow cytometric evaluation of p53, bax and bcl-2 proteins
Determination by flow cytometry of different proteins involved in the apoptotic process offers rapid and objective quantification of protein expression (34) (35) (36) (37) . Under the same exposure conditions described above, 1ϫ10 6 cells were fixed and permeabilized by a commercially available kit, namely Leucoperm solution A and B (Serotec, Oxford, UK). They were then incubated with 10 µl of each antibody, i.e. FITC p53 (35 µg/ml; Novocastra, Newcastle, UK) against phosphorylated and non-phosphorylated protein, FITC bcl-2 (200 µg/ml; Serotec) and bax (200 µg/ml; Santa Cruz Biotechnology, Santa Cruz, CA) or isotype-matched negative control (Serotec). The cells were washed and incubated with 10 µl of the FITC-labeled secondary antibody for the bax-stained cells (5 µg/ml; Serotec). Finally, the cells were washed and resuspended in 0.2 ml of 1% paraformaldehyde. The cells were then analyzed to quantify FITC binding by flow cytometry. From each sample 10 000 cells were analyzed and non-specific binding was excluded by gating around those cells which were labeled by the isotype negative control antibodies.
Statistical analysis
All data are the mean Ϯ SD of two experiments. Fisher's exact test was adopted for statistical evaluation of the results. A t-test was used for the analysis of protein level meaurements. All P values are two-sided. Precise P values are given. All statistical analyses were performed in GraphPad InStat version 3.00 for Windows 95, GraphPad Software, San Diego, CA. Figure 2 shows the growth curve of Jurkat cells at different time points and after treatment with different concentrations of sulforaphane. When the harvested cells were counted, the numbers of control cells continued to increase, whereas the numbers of treated cells decreased in a time-and dosedependent manner. The maximum effect was registered after 48 h of treatment and at a concentration of 30 µM sulforaphane. In fact, the number of cells decreased from~6 to 1ϫ10 6 . These changes appear to be irreversible, persisting when the treated cells were recultured in sulforaphane-free medium (data not shown). Only a slight decrease in the number of viable cells in cultures treated with Myr or GRA 30 µM was observed. The ID 50 , as measured by the number of viable cells in cultures 24 h after the addition of GRA plus Myr, was seen at a concentration of~15 µM.
Results

Treatment with sulforaphane causes time-and dose-dependent reduction in cell number
Sulforaphane but not GRA induces cell-cycle arrest
To elucidate the rate at which sulforaphane altered cell-cycle progression, cell-cycle progression was determined at several time points. Table I No effect on cell-cycle progression was detected in cell cultures treated with enzyme only. A very slight effect was observed with GRA after 48 h of treatment.
Sulforaphane but not GRA induces apoptosis in a time-and dose-dependent fashion
Apoptosis was observed at the highest dose of sulforaphane and at late stages during the treatment (at 24 and 48 h). It manifested by appearance of cells with decreased DNA content, identified in the DNA content distributions as cells with DNA values below that of G 1 cells ('sub-G 1 cells'). Thus, as an example, after 8 h of treatment with 30 µM sulforaphane, only 2% of apoptotic cells were found. This fraction significantly increased to 8 and 38% after 24 and 48 h of treatment, respectively (Table II) .
The proportion of cells reactive with the annexin V-FITC conjugate indicates that target cells start to die as late as 24 h after effector and target mixing by an apoptosis-related mechanism. Thus, after 8 h of treatment of Jurkat cells with 30 µM sulforaphane, the incidence of annexin V pos and PI neg cells-i.e. apoptotic cells-was 5% (vs 1% in the control). They increased to 16% after 24 h and 32% after 48 h (Table II) . Membrane permeabilization, revealed by PI uptake (annexin V pos -PI pos ), presented the same kinetics (data not shown). There was only 3% of annexin V pos /PI pos cells after 8 h of treatment. This fraction increased to 14 and 30% after 24 and 48 h of treatment, respectively. No effects on apoptotic event induction were detected in cell cultures treated with GRA or with Myr (data not shown).
Sulforaphane modulates p53 and bax protein expression, but does not affect bcl-2 protein expression
To examine the effect of sulforaphane on levels of p53, bcl-2 and bax, cells were treated for 48 h with sulforaphane 30 µM. Apoptotic cells were gated, based on their changed FSC and SSC distribution, and p53, bcl-2 and bax proteins were then quantified. Figure 3 shows histograms of p53, bcl-2 and bax protein levels following incubation without compound or sulforaphane. p53 and bax expression were found to be increased in treated cells relative to the untreated cells. Typically, p53 and bax protein levels showed~7-and 3-fold increase with regard to the control, respectively. bcl-2 protein level was only slightly affected.
Discussion
What this study adds to our knowledge is the first demonstration that sulforaphane, generated from GRA by Myr hydrolysis but not its precursor GL, is able to induce cell-cycle arrest and apoptosis or necrosis in a leukemic cell line. The bioactivity of GRA was observed only in the presence of Myr, thereby demonstrating that the hydrolytic product sulforaphane is the biologically active agent, according to the evidence that ITCs are~1000-fold more potent than the precursors (38).
Treatment of Jurkat cells with generated sulforaphane resulted in a potent inhibition of cell growth in vitro. Flow cytometric DNA analysis of treated cultures revealed that complete derangement of cell-cycle progression was responsible for the inhibition of tumor-cell growth. Examination of the Jurkat cells after a 48 h incubation with various doses of sulforaphane revealed a marked increase in the percentage of cells in the G 2 /M cell-cycle phase. Such behavior is in line with the recent finding that synthetic sulforaphane is capable of causing cell-cycle arrest in the G 2 /M phase in the HT29 colon cancer cell line (19) .
Moreover, simultaneous analysis of cell-cycle progression (sub-G 1 peak) and loss of phospholipid asymmetry of the plasma membrane in sulforaphane-treated cultures revealed a strictly dose-and time-dependent increase in the percentage of Jurkat cells bearing the flow cytometric characteristics of apoptosis. The latter became apparent after 24 h of incubation. Taken together, these observations imply that the growth inhibition of Jurkat cells produced by sulforaphane (as generated in situ from the GRA-Myr mixture) results from a combination of apoptosis and of cell-cycle derangements in which G 2 /M arrest is a key event. The simultaneous appearance of G 2 /M arrest and apoptosis clearly indicates that cell death is a primary direct effect due to the hydrolytic product of GRA, and not to activation of apoptotic pathways as a consequence of cells' inability to overcome growth arrest and proceed through the cell cycle.
Interactions between p53, bax, bcl-2 and its associated proteins have been postulated to form one pathway of apoptosis (39, 40) . We used flow cytometric analysis to evaluate the levels of p53, bcl-2 and bax proteins, after treatment with GRA plus Myr. We found that the generated sulforaphane increased p53 and bax protein levels, whereas bcl-2 levels remained unchanged. These observations support the hypothesis that induction of p53 expression may be an important step during the sulforaphane-induced apoptosis. Apoptosis is activated by many oxidative agents (41), and Payen et al. (42) indicated a sulforaphane-mediated production of reactive oxygen species. Moreover, Zhang (43) demonstrated that ITCs, and sulforaphane among these, are taken by cells predominantly through GSH conjugation reactions in cells. Sulforaphane may induce oxidative stress by reacting with and depleting the intracellular GSH pool, which may then induce apoptosis. The molecular mechanism may be mediated by the c-Jun Nterminal kinase, as demonstrated for other ITCs (44) and, therefore, by p53 known to be a substrate of this kinase (45) . Otherwise, Bonnesen et al. (46) demonstrated that sulforaphane is not associated with DNA damage in colon cell lines, as assessed by comet assay. bax has been found to be up-regulated during apoptosis in studies on several other cell types (47, 48) . p53 is a direct transcriptional activator of the bax gene (48) . So in the presence of increased p53 expression, it is scarcely surprising that bax expression is also affected. The induction of apoptosis recorded in this study seems to be dependent on p53 gene. This is contrary to a recent report (19) where sulforaphane-induced HT29 cell death is not associated with a change in p53 protein expression but is accompanied by an over expression of bax. On the other hand, Huang et al. (18) demonstrated an essential role of p53 in the induction of apoptosis by phenylethyl ITC in a mouse epidermal cell line. However, it should be borne in mind that many of the genes and proteins thought to be involved in the apoptotic process may have cell-and injury-type-dependent roles (36) .
The present study also demonstrates for the first time that high doses of sulforaphane are capable of inducing necrosis. In the Jurkat cells studied by us, sulforaphane induced necrosis after prolonged exposure (48 h) to the highest concentration (30 µM) investigated. This suggests that very high levels of exposure to produced sulforaphane can cause some form of intensive cell toxicity.
We conclude that the sulforaphane produced in situ is able to exert G 2 /M phase cell-cycle arrest and produce apoptotic death (and at very high doses even necrosis) of Jurkat tumor cells. The end result of these effects is potent inhibition of the leukemic cell growth. We propose that sulforaphane could be tested as a potential chemopreventive and chemotherapeutic agent, also in the light of its effects on xenobiotic metabolism that were detected in a range of concentrations similar to that used in this study. In particular, sulforaphane is able to induce in vitro phase II detoxifying enzymes at 5 µM, with a maximal activity at 50 µM and a decrease of activity at 100 µM (49) . Experimental investigations into ways in which sulforaphane could be employed in selective chemoprotective strategies for subjects affected by pre-neoplastic lesions could also be worthwhile. Further in-depth in vitro studies have to be performed to compare the activity of sulforaphane on different cell types. In vivo studies may then lead to clinical trials to investigate the therapeutic potential of sulforaphane.
